<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To examine the antitumor activity of a new derivative of ciprofloxacin called methoxyphenylcipro (CMPP) </plain></SENT>
<SENT sid="1" pm="."><plain>Cell viability was assessed using the <z:chebi fb="0" ids="53233">MTT</z:chebi> assay and apoptotic cells and reactive oxygen species were evaluated using flow cytometry </plain></SENT>
<SENT sid="2" pm="."><plain>Results revealed that CMPP induces antiproliferative activity against <z:hpo ids='HP_0003002'>breast cancer</z:hpo> cells and <z:hpo ids='HP_0002861'>melanoma</z:hpo> and to a lesser extent against <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>Interestingly, compared to ciprofloxacin, CMPP-induced a selective cytotoxicity against human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells but not human <z:mpath ids='MPATH_458'>normal</z:mpath> fibroblasts </plain></SENT>
<SENT sid="4" pm="."><plain>The potential of CMPP to inhibit cellular growth in MD-MB-486 <z:hpo ids='HP_0003002'>breast cancer</z:hpo> cells and MV3 <z:hpo ids='HP_0002861'>melanoma</z:hpo> cells was largely due to induction of caspase-dependent <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, as confirmed by caspase-3 activation and cleavage of its substrate PARP </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, results indicated that CMPP-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> is mediated by generation of reactive oxygen species </plain></SENT>
<SENT sid="6" pm="."><plain>These findings revealed that CMPP has a selective antitumor activity against <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells and warrants further clinical evaluation </plain></SENT>
</text></document>